Pathogenesis of respiratory failure in coronavirus disease (COVID-19)
DOI:
https://doi.org/10.33910/2687-1270-2020-1-4-285-293Keywords:
COVID-19, SARS-CoV-2, respiratory failure, acute respiratory distress syndrome, cytokine stormAbstract
The review presents the results of experimental and clinical studies and observations. It allows to draw conclusions about the causes and mechanisms of the development of acute respiratory failure in severe COVID-19. The paper compares SARS-CoV-2, MERS-CoV and SARS-CoV. It explores the role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19, the mechanisms of the development of acute respiratory distress syndrome and hypoxemia, the adverse consequences of hypercytokinemia (cytokine storm), and the neurogenic mechanism of respiratory failure. It is emphasized that the adverse processes in the lungs of patients with COVID-19 are caused not so much by the direct action of the virus, but, rather, by the hyperreactivity of the immune system. The paper also focuses on the ability of SARS-CoV-2 for neuroinvasion, which leads to the spread of infection to the brain stem and structures of the respiratory center.
Finally, based on the literature data, it is concluded that the pathogenesis of respiratory failure in COVID-19 has multiple causes and is characterized by diffuse and exudative damage to the alveoli, deterioration of ventilation-perfusion relations, development of fibrosis, thrombus formation, and hypoxemia. It is emphasized that the study of the central, neurogenic mechanisms of respiratory failure as well as their correlation with neurological symptoms contributes to a deeper understanding of the pathogenesis of COVID-19 and may be essential for the prevention and treatment of respiratory failure caused by SARS-CoV-2.
References
Baig, A. M. (2020) Computing the effects of SARS-CoV-2 on respiration regulatory mechanisms in COVID-19. ACS Chemical Neuroscience, vol. 11, no. 16, pp. 2416–2421. DOI: 10.1021/acschemneuro.0c00349 (In English)
Baig, A. M., Khaleeq, A., Ali, U., Syeda, H. (2020) Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chemical Neuroscience, vol. 11, no. 7, pp. 995−998. DOI: 10.1021/acschemneuro.0c00122 (In English)
Bateneva, T. (2020) Akademik Aleksandr Chuchalin rasskazal “RG” o tajnakh koronavirusa [Academician Alexander Chuchalin told “RG” about the secrets of the coronavirus]. Rossijskaya gazeta, 19 April. [Online]. Available at: https://rg.ru/2020/04/19/nauka-shag-za-shagom-otkryvaet-tajny-koronavirusa.html (accessed 19.04.2020). (In Russian)
Behrens, E. M, Koretzky, G. A. (2017) Review: Cytokine storm syndrome: Looking toward the precision medicine era. Arthritis & Rheumatology, vol. 69, no. 6, pp. 1135–1143. DOI: 10.1002/art.40071 (In English)
Chen, N., Zhou, M., Dong, X. et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, vol. 395, no. 10223, pp. 507–513. DOI: 10.1016/S0140-6736(20)30211-7 (In English)
Chuchalin, A. G. (2004) Tyazhelyj ostryj respiratornyj sindrom [Severe acute respiratory syndrome (SARS)]. Terapevticheskii arhiv — Therapeutic Archive, vol. 79, no. 3, pp. 5–11. (In Russian)
Ding, Y., He, L., Zhang, Q. et al. (2004) Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: Implications for pathogenesis and virus transmission pathways. Journal of Pathology, vol. 203, no. 2, pp. 622–630. DOI: 10.1002/path.1560 (In English)
Donoghue, M., Hsieh, F., Baronas, E. et al. (2000) A novel angiotensin-converting enzyme‐related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1‐9. Circulation Research, vol. 87, no. 5, pp. e1–e9. DOI: 10.1161/01.res.87.5.e1 (In English)
Eriksson, O., Hultström, M., Persson, B. et al. (2020) Mannose-binding lectin is associated with thrombosis and coagulopathy in critically ill COVID-19 patients. Thrombosis and Haemostasis. DOI: 10.1055/s-0040-1715835 (In English)
Fehr, A. R., Perlman, S. (2015) Coronaviruses: An overview of their replication and pathogenesis. In: H. Maier, E. Bickerton, P. Britton (eds.). Coronaviruses. Methods in molecular biology. Vol. 1282. New York: Humana Press, 23 p. DOI: 10.1007/978-1-4939-2438-7_1 (In English)
Ferrario, C. M., Jessup, J., Chappell, M. C. et al. (2005) Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation, vol. 111, no. 20, pp. 2605–2610. DOI: 10.1161/circulationaha.104.510461 (In English)
Gorbalenya, A. E., Baker, S. C., Baric, R. C. et al. (2020) The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, vol. 5, no. 4, pp. 536–544. DOI: 10.1038/s41564-020-0695-z (In English)
Gu, J., Gong, E., Zhang, B. et al. (2005) Multiple organ infection and the pathogenesis of SARS. Journal of Experimental Medicine, vol. 202, no. 3, pp. 415–424. DOI: 10.1084/jem.20050828 (In English)
Hadziefendic, S., Haxhiu, M. A. (1999) CNS innervation of vagal preganglionic neurons controlling peripheral airways: A transneuronal labeling study using pseudorabies virus. Journal of Autonomic Nerve System, vol. 76, no. 2-3, pp. 135–145. DOI: 10.1016/s0165-1838(99)00020-x (In English)
Hamming, I., Timens, W., Bulthuis, M. L. et al. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology, vol. 203, no. 2, pp. 631–637. DOI: 10.1002/path.1570 (In English)
Harmer, D., Gilbert, M., Borman, R., Clark, K. L. (2002) Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Letters, vol. 532, no. 1-2, pp. 107–110. DOI: 10.1016/ s0014-5793(02)03640-2 (In English)
Huang, C., Wang, Y., Li, X. et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, vol. 395, no. 10223, pp. 497–506. DOI: 10.1016/S0140-6736(20)30183-5 (In English)
Imai, Y., Kuba, K., Rao, S. et al. (2005) Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature, vol. 436, no. 7047, pp. 112–116. DOI: 10.1038/nature03712 (In English)
Kalia, M, Mesulam, M. M. (1980) Brain stem projections of sensory and motor components of the vagus complex in the cat: II. Laryngeal, tracheobronchial, pulmonary, cardiac, and gastrointestinal branches. Journal of Comparative Neurology, vol. 193, no. 2, pp. 467–508. DOI: 10.1002/cne.901930211 (In English)
Khan, S., Ali, A., Siddique, R., Nabi, G. (2020) Novel coronavirus is putting the whole world on alert. Journal of Hospital Infection, vol. 104, no. 3, pp. 252–253. DOI: 10.1016/j.jhin.2020.01.019 (In English)
Komorowski, M., Aberegg, S. K. (2020) Using applied lung physiology to understand COVID-19 patterns. British Journal of Anaesthesia, vol. 125, no. 3, pp. 250–253. DOI: 10.1016/j.bja.2020.05.019 (In English)
Kuba, K., Imai, Y., Rao, S. et al. (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine, vol. 11, no. 8, pp. 875–879. DOI: 10.1038/nm1267 (In English)
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R. et al. (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. European Archive of Oto-Rhino-Laryngology, vol. 277, no. 8, pp. 2251–2261. DOI: 10.1007/s00405-020-05965-1 (In English)
Leonard, E. M., Salman, S., Nurse, C. (2018) Sensory processing and integration at the carotid body tripartite synapse: Neurotransmitter functions and effects of chronic hypoxia. Frontiers in Physiology, vol. 9, article 225. DOI: 10.3389/fphys.2018.00225 (In English)
Li, Y. C., Bai, W. Z., Hashikawa, T. (2020) The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. Journal of Medical Virology, vol. 92, no. 6, pp. 552–555. DOI: 10.1002/jmv.25728 (In English)
Li, Y. C., Bai, W. Z., Hirano, N. et al. (2012) Coronavirus infection of rat dorsal root ganglia: Ultrastructural characterization of viral replication, transfer, and the early response of satellite cells. Virus Research, vol. 163, no. 2, pp. 628–635. DOI: 10.1016/j.virusres.2011.12.021 (In English)
Li, Y. C., Bai, W. Z., Hirano, N. et al. (2013) Neurotropic virus tracing suggests a membranous‐coating‐mediated mechanism for transsynaptic communication. Journal of Comparative Neurology, vol. 521, no. 1, pp. 203–212. DOI: 10.1002/cne.23171 (In English)
Manganelli, F., Vargas, M., Iovino, F. et al. (2020) Brainstem involvement and respiratory failure in COVID-19. Neurological Sciences, vol. 41, no. 6, pp. 1663–1665. DOI: 10.1007/s10072-020-04487-2 (In English)
Matsuda, K., Park, C. H., Sunden, Y. et al. (2004) The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice. Veterinary Pathology, vol. 41, no. 2, pp. 101–107. DOI: 10.1354/vp.41-2- 101 (In English)
Millan-Oñate, J., Millan, W., Mendoza, L. A. et al. (2020) Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin. Annals of Clinical Microbiology and Antimicrobials, vol. 19, no. 1, article 16. DOI: 10.1186/s12941-020-00358-y (In English)
Paniz‐Mondolfi, A., Clare Bryce, Z., Grimes, R. E. (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). Journal of Medical Virology, vol. 92, no. 7, pp. 699–702. DOI: 10.1002/jmv.25915 (In English)
Román, G. C., Spencer, P. S., Reis, J. et al. (2020) The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. Journal of the Neurological Sciences, vol. 414, article 116884. DOI: 10.1016/j.jns.2020.116884 (In English)
Smith, J. C., Ellenberger, H. H., Ballanyi, K. et al. (1991) Pre-Bötzinger complex: A brainstem region that may generate respiratory rhythm in mammals. Science, vol. 254, no. 5032, pp. 726−729. DOI: 10.1126/science.1683005 (In English)
Sommerstein, R., Kochen, M. M., Messerli, F. H., Gräni, Ch. (2020) Coronavirus Disease 2019 (COVID-19): Do angiotensin-converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect? Journal of the American Heart Association, vol. 9, no. 7, article e016509. DOI: 10.1161/JAHA.120.016509 (In English)
Tay, M. Z, Poh, C. M., Rеnia, L. et al. (2020) The trinity of COVID-19: Immunity, inflammation and intervention. Nature Reviews Immunology, vol. 20, no. 6, pp. 363–374. DOI: 10.1038/s41577-020-0311-8 (In English)
Wong, J. P., Viswanathan, S., Wang, M. et al. (2017) Current and future developments in the treatment of virus-induced hypercytokinemia. Future Medicinal Chemistry, vol. 9, no. 2, pp. 169–178. DOI: 10.4155/fmc-2016-0181 (In English)
Wu, Y., Xu, X., Chen, Z. et al (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behavior, and Immunity, vol. 87, pp. 18–22. DOI: 10.1016/j.bbi.2020.03.031 (In English)
Xu, J., Zhong, S., Liu, J. et al. (2005) Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis. Clinical Infectious Diseases, vol. 41, no. 8, pp. 1089–1096. DOI: 10.1086/444461 (In English)
Yang, G., Tan, Z., Zhou, L. et al. (2020) Effects of angiotensin II receptor blockers and ace (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients with COVID-19 and hypertension: A single-center retrospective study. Hypertension, vol. 76, no. 1, pp. 51–58. DOI: 10.1161/HYPERTENSIONAHA.120.15143 (In English)
Yu, F., Du, L., Ojcius, D. M. et al. (2020) Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes and Infection, vol. 22, no. 2, pp. 74–79. DOI: 10.1016/j.micinf.2020.01.003 (In English)
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Nina P. Aleksandrova
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The work is provided under the terms of the Public Offer and of Creative Commons public license Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows an unlimited number of persons to reproduce and share the Licensed Material in all media and formats. Any use of the Licensed Material shall contain an identification of its Creator(s) and must be for non-commercial purposes only.
